Activity Details

Free CE
0.75 Contact Hour(s)
Released: August 26, 2019
Expires: August 25, 2020
45 minutes to complete

Provided By

This continuing education activity is provided by Vindico Medical Education.

Statement of Commercial Support

This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply American Nurses Credentialing Center (ANCC) Commission on Accreditation endorsement of any commercial products.

Target Audience

The intended audience for this activity is long-term care directors of nursing, advance practice nurses, nurses, and other health care professionals involved in the management of patients with chronic obstructive pulmonary disease (COPD).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Incorporate new GOLD guidelines into practice for the assessment and management of patients with COPD.
  • Assess current evidence about the use of combined therapy in the treatment of patients with COPD.
  • Apply new evidence about the use of nebulizers and inhalers to improve the efficacy of inhaled COPD medications.

Activity Description

This continuing education (CE) activity is based on the slides and lectures presented by the faculty at the live program, “Improving Outcomes in Chronic COPD Care,” on June 5, 2019, at the Planet Hollywood Resort and Casino in Las Vegas, NV.

Statement of Educational Need

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality worldwide. Due to the progressive nature of COPD, a significant number of diagnosed individuals will be admitted to a long-term care facility during their disease. Reports such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, which was extensively revised in 2017 and updated in 2019, continue to provide guidance regarding optimal diagnostic and treatment algorithms for COPD, while new and emerging therapies and devices look to provide a more personalized therapeutic approach. Integration of these recommendations and therapeutic approaches into current management paradigms has the potential to benefit patients with COPD. Within this educational activity, a panel of experts in the field will evaluate COPD in long-term care facilities, assess therapies and delivery devices for optimal administration of medications, and provide direction to incorporate GOLD guidelines into practice for the enhancement of patient outcomes. The presentation of 2 COPD cases will further provide guidance for the optimal diagnosis and management of patients with COPD.


  • Getting With the GOLD in Long-term Care Settings
    Charles Michael Bobbitt MSN, RN, CDONA
  • GOLD Standards in the Treatment of COPD in the Long-term Care Setting
    Albert Riddle, MD, CMD, HMDC
  • COPD Case Challenges
    Daniel Haimowitz, MD, CMD

Activity Chair

Daniel Haimowitz, MD, CMD
Multi-facility Medical Director
Private Practice
Levittown, PA
  • No relevant financial relationships to disclose.


Charles Michael Bobbitt, MSN, RN, CDONA
Nursing Faculty
El Centro College
Dallas County Community College District
Dallas, TX
  • Salary (spouse): Johnson & Johnson
    Ownership Interest: Johnson & Johnson

Albert Riddle, MD, CMD, HMDC
Riddle Medical LLC
Multi-facility Medical Director
Tarrytown, NY
  • Speakers Bureau: Acadia, Janssen

Nurse Planners report the following relationship(s):
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Charles Michael Bobbitt MSN, RN, CDONA
Salary (spouse): Johnson & Johnson
Ownership Interest: Johnson & Johnson

Conflict of Interest Policy/Disclosure Statement

In accordance with the American Nurses Credentialing Center’s Standards for Commercial Support, all CNE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CNE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CNE activity content over which the individual has control. Relationship information appears above and below.

Vindico Medical Education Staff:
No relevant financial relationships to disclose.

Signed Disclosure(s) are on file at Vindico Medical Education, Office of Medical Education and Compliance.

Accreditation Statement

Vindico Medical Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation of Credit

Vindico Medical Education will provide 0.75 contact hours for nurses.

This activity is approved for 0.75 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19083831. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Instructions for Receiving Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, watch the presentation, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Learner-Paced Contact Hour Certificate.


The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

CME Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.